Issue
Number 348
November 11, 2002
CONTENTS OF THIS ISSUE
- CDC releases ACIP recommendations for using
yellow fever vaccine
- Bruce Gellin, MD, MPH, selected to head federal
government's National Vaccine Program Office
- Two NFID reports on improving immunization rates
in underserved populations now online
- New! Volume Five of "Unprotected People" stories
is now available online from IAC
- "Hepatitis and Corrections" webcast available on
the American Correctional Association's website
- CDC reports on adverse events associated with
yellow fever vaccination
- CDC reports on global progress in containing
wild polioviruses
- New translation! Influenza VIS now in Armenian
- NFID's Sixth Annual Conference on Vaccine
Research set for May 5-7, 2003
- World Vaccine Congress Montreal to be held
April 7-9, 2003
----------------------------------------------------------
Back to Top
(1 of 10)
November 11, 2002
CDC RELEASES ACIP RECOMMENDATIONS FOR USING YELLOW FEVER VACCINE
The Centers for Disease Control and Prevention (CDC) published "Yellow Fever
Vaccine: Recommendations of the Advisory Committee on Immunization Practices
(ACIP), 2002" in the November 8 issue of "MMWR Recommendations and
Reports." The summary is reprinted below.
**********************
This report updates CDC's recommendations for using yellow fever vaccine
(CDC. Yellow Fever Vaccine: Recommendations of the Advisory Committee on
Immunizations Practices: MMWR 1990;39 [No. RR-6]1-6). The 2002
recommendations include new or updated information regarding 1) reports of
yellow fever vaccine-associated viscerotropic disease (previously reported
as febrile multiple organ system failure); 2) use of yellow fever vaccine
for pregnant women and persons infected with human immunodeficiency
virus (HIV); and 3) concurrent use of yellow fever vaccine with other
vaccines. A link to this report and other information related to yellow
fever can be accessed at the website for Travelers' Health, Division of
Global Migration and Quarantine, National Center for Infectious Diseases,
CDC, at
http://www.cdc.gov/travel/index.htm and through the website for the
Division of Vector-Borne Infectious Diseases, National Center for Infectious
Diseases, CDC, at
http://www.cdc.gov/ncidod/dvbid/yellowfever/index.htm
**********************
To obtain the complete text of the report online, go to:
http://www.cdc.gov/mmwr/preview/mmwrhtml/rr5117a1.htm
To obtain a camera-ready (PDF format) copy of this issue of MMWR
Recommendations and Reports, go to:
http://www.cdc.gov/mmwr/PDF/rr/rr5117.pdf
The PDF version includes a free CDC-sponsored continuing education activity
that can be completed online or submitted via U.S. mail for CME, CEU, or CNE
credit. Simply read the MMWR report, answer the questions at the end of the
report, and follow the instructions for submitting your answers.
HOW TO OBTAIN A FREE ELECTRONIC SUBSCRIPTION TO THE MMWR:
To obtain a free electronic subscription to the "Morbidity and Mortality
Weekly Report" (MMWR), visit CDC's MMWR website at:
http://www.cdc.gov/mmwr Select
"Free Subscription" from the menu at the left of the screen. Once you have
submitted the required information, weekly issues of the MMWR and all
new ACIP statements (published as MMWR's "Recommendations and Reports") will
arrive automatically by email.
----------------------------------------------------------
Back to Top
(2 of 10)
November 11, 2002
BRUCE GELLIN, MD, MPH, SELECTED TO HEAD FEDERAL GOVERNMENT'S NATIONAL
VACCINE PROGRAM OFFICE
The Immunization Action Coalition congratulates Bruce Gellin, MD, MPH, on
being named Director of the National Vaccine Program Office (NVPO),
Office of Public Health and Science, Office of the Secretary,
Department of Health and Human Services. He began his new duties October 28.
A graduate of the University of North Carolina (Morehead Scholar) and
Cornell University Medical College, Dr. Gellin is an infectious disease
expert with training in epidemiology. He has had broad experience in public
health aspects of infectious diseases, having most recently been Director of
the National Network for Immunization Information (NNii), a special program
of seven medical professional societies. (NNii activities will continue
under the leadership of Louis Z. Cooper, MD, immediate past president of the
American Academy of Pediatrics.)
NVPO brings together groups that play a key role in immunization--such as
federal and state agencies, municipalities, the public, health care
providers, and the commercial vaccine industry--to collaborate in the
pursuit of preventing infectious diseases through immunization.
To access the NVPO website, go to:
http://www.cdc.gov/od/nvpo/who.htm
----------------------------------------------------------
Back to Top
(3 of 10)
November 11, 2002
TWO NFID REPORTS ON IMPROVING IMMUNIZATION RATES IN UNDERSERVED POPULATIONS
ARE NOW ONLINE
Two reports on improving immunization rates in underserved populations are
now available on the website of the National Foundation for Infectious
Diseases (NFID). They are titled "A Report on Reaching Underserved Ethnic
and Minority Populations to Improve Pediatric Immunization Rates," which is
24 pages, and "A Report on Reaching Underserved Ethnic and Minority
Populations to Improve Adolescent and Adult Immunization Rates," which is 32
pages.
Each report summarizes the work of a roundtable of U.S. and Canadian
immunization experts that focused on the problem of vaccinating underserved
populations in the United States and Canada. A variety of organizations,
representing a diversity of government, as well as ethnic and multicultural
groups, contributed. Included in each report are summaries of faculty
presentations, a summary of key issues, conclusions, and a reference list.
To obtain a camera-ready (PDF) copy of the pediatric report, go to:
http://www.nfid.org/publications/pediatricwhitepaper.pdf
To obtain a camera-ready (PDF) copy of the adolescent and adult report, go
to:
http://www.nfid.org/publications/adoladultwhitepaper.pdf
----------------------------------------------------------
Back to Top
(4 of 10)
November 11, 2002
NEW! VOLUME FIVE OF "UNPROTECTED PEOPLE" STORIES IS NOW AVAILABLE ONLINE
FROM IAC
Visit the website of the Immunization Action Coalition (IAC) to obtain the
latest collection of "Unprotected People: Stories of People Who Died or
Suffered from Vaccine-Preventable Diseases." Volume Five comprises the ten
latest personal stories or case reports published in "IAC EXPRESS."
To obtain Volume Five in HTML format, go to:
http://www.immunize.org/catg.d/T2015.htm
To obtain Volume Five in camera-ready (PDF) format, go to:
http://www.immunize.org/catg.d/T2015.pdf
To access any of the five volumes in HTML or PDF format, go to:
http://www.immunize.org/catg.d/2057unpr.htm
----------------------------------------------------------
Back to Top
(5 of 10)
November 11, 2002
"HEPATITIS AND CORRECTIONS" WEBCAST AVAILABLE ON THE AMERICAN CORRECTIONAL
ASSOCIATION'S WEBSITE
"Hepatitis and Corrections," a national webcast hosted by the American
Correctional Association (ACA), is now available on the association's
website. The webcast is based on a presentation made August 5 at the 132nd
Congress of Correction in Anaheim, CA.
The aim of the webcast is to provide insight on efforts to reduce the spread
of viral hepatitis inside correctional facilities. Speakers include Harold
Margolis, MD, Director, Division of Viral Hepatitis, Centers for Disease
Control and Prevention, as well as officials from the criminal justice and
corrections departments of Texas, Louisiana, and Pennsylvania.
To access the webcast, go to:
http://www.aca.org/media_20020805b_hepatitis.htm
To take the program as a course at no charge, and receive CEU and CME
credits, register on ACA's Online Corrections Academy website at
http://www.aca-oca.org/
For further information, call the Online Corrections Academy at (800)
222-5646, extension 1854.
----------------------------------------------------------
Back to Top
(6 of 10)
November 11, 2002
CDC REPORTS ON ADVERSE EVENTS ASSOCIATED WITH YELLOW FEVER VACCINATION
The Centers for Disease Control and Prevention (CDC) published "Adverse
Events Associated with 17-D-Derived Yellow Fever Vaccination--United States,
2001-2002" in the November 8 issue of "Morbidity and Mortality Weekly
Report" (MMWR). The press summary supplied by CDC is reprinted below.
**********************
Between May 2001-October 2002, CDC received reports of six cases of serious
neurologic (4) and systemic (2) adverse events associated with yellow fever
vaccination. These events are rare. Clinicians are encouraged to report to
the Vaccine Adverse Event Reporting System patients with fever (more than 24
hours) or systemic illness within 30 days following vaccination. Despite
these rare case reports, yellow fever is an important vaccine-preventable
disease among travelers to, and those living in, the tropics of Africa and
South America. Because of potential for high risk exposure to and severity
of yellow fever infection, and the availability of an efficacious vaccine,
ACIP and CDC continue to recommend yellow fever vaccination for persons aged
9 months and older traveling to countries where yellow fever is endemic or
epidemic.
***********************
To obtain the complete text of the article online, go to:
http://www.cdc.gov/mmwr/preview/mmwrhtml/mm5144a1.htm
To obtain a camera-ready (PDF format) copy of this issue of MMWR, go to:
http://www.cdc.gov/mmwr/PDF/wk/mm5144.pdf
----------------------------------------------------------
Back to Top
(7 of 10)
November 11, 2002
CDC REPORTS ON GLOBAL PROGRESS IN CONTAINING WILD POLIOVIRUSES
The Centers for Disease Control and Prevention (CDC) published "Global
Progress Toward Laboratory Containment of Wild Polioviruses--July
2001-August 2002" in the November 8 issue of "Morbidity and Mortality Weekly
Report" (MMWR). The press summary supplied by CDC is reprinted below.
************************
Since the World Health Assembly resolved in 1988 to eradicate poliomyelitis,
the number of countries in which wild poliovirus is endemic has decreased
from 125 to 10 in 2001. The Global Commission for the Certification of the
Eradication of Poliomyelitis will declare the world polio-free when all
regions have documented the absence of wild poliovirus transmission for at
least 3 consecutive years and when laboratories with wild poliovirus
materials have implemented appropriate containment conditions. This report
describes preparations for laboratory containment, creation of a global
inventory of laboratories and institutions retaining wild poliovirus, and
summarizes global progress since July 2001. The data indicate that there has
been substantial progress in identifying laboratories with wild poliovirus
materials and in conducting national wild poliovirus inventories.
************************
To obtain the complete text of the article online, go to:
http://www.cdc.gov/mmwr/preview/mmwrhtml/mm5144a2.htm
To obtain a camera-ready (PDF format) copy of this issue of MMWR, go to:
http://www.cdc.gov/mmwr/PDF/wk/mm5144.pdf
----------------------------------------------------------
Back to Top
(8 of 10)
November 11, 2002
NEW TRANSLATION! INFLUENZA VIS NOW IN ARMENIAN
The 2002-2003 Influenza Vaccine Information Statement (VIS) in Armenian is
now available on the Immunization Action Coalition (IAC) website. IAC
gratefully acknowledges the County of Los Angeles, Department of Health
Services Immunization Program for providing the Armenian translation.
To obtain a camera-ready (PDF) copy of the influenza VIS in Armenian, go to:
http://www.immunize.org/vis/ar_flu02.pdf
To obtain a copy camera-ready (PDF) of the influenza VIS in English, go to:
http://www.immunize.org/vis/2flu.pdf
For more information about the use of VISs, and for VISs in a total of 28
languages, visit IAC's VIS web page at
http://www.immunize.org/vis/
----------------------------------------------------------
Back to Top
(9 of 10)
November 11, 2002
NFID'S SIXTH ANNUAL CONFERENCE ON VACCINE RESEARCH SET FOR MAY 5-7, 2003
The National Foundation for Infectious Diseases (NFID) announced the Sixth
Annual Conference on Vaccine Research will take place at the Crystal Gateway
Marriott, Arlington, VA, on May 5-7, 2003.
Intended to further networking and scientific collaboration among vaccine
researchers, the conference will focus on basic immunology, vaccine
development, clinical testing, and vaccine regulation.
For information, call Sharon Cooper-Kerr or
Sheena Majette at (301) 656-0003, extension 19, or email them at
vaccine@nfid.org
----------------------------------------------------------
Back to Top
(10 of 10)
November 11, 2002
WORLD VACCINE CONGRESS MONTREAL TO BE HELD APRIL 7-9, 2003
World Vaccine Congress Montreal is set for April 7-9, 2003, at the Hilton
Montreal Bonaventure, Montreal, Canada. It is intended for senior people
across the North American vaccine industry.
For information, call Sarah Butt at +44 (0)20 7827-5962 or email her at
sarah.butt@terrapin.com
|
